Lista de obras - Adrian Newland - Dominio Público Uruguay

A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia

artículo científico publicado en 2016

Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults

artículo científico publicado en 2007

Adult idiopathic thrombocytopenic purpura

artículo científico publicado en 2003

Alpha-galactosylceramide-driven expansion of human natural killer T cells is inhibited by prednisolone treatment

artículo científico publicado en 2004

An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura

artículo científico publicado en 2006

Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry

artículo científico publicado en 2010

Cell death in leukemia: passenger protein regulation by topoisomerase inhibitors

artículo científico publicado en 2007

Current Management of Primary Immune Thrombocytopenia

artículo científico publicado en 2015

Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside

artículo científico publicado en 2010

Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib

artículo científico publicado en 2008

Differential and tumor-specific expression of CD160 in B-cell malignancies ⬇️

artículo científico publicado el 28 de junio de 2011

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

artículo científico publicado en 2008

Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura

artículo científico publicado en 2006

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

artículo científico publicado en 2008

Emerging strategies to treat chronic immune thrombocytopenic purpura

artículo científico publicado en 2008

Fatigue in immune thrombocytopenia

artículo científico publicado en 2015

Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults

artículo científico publicado en 2002

Fostamatinib: a review of its clinical efficacy and safety in the management of chronic adult immune thrombocytopenia

artículo científico publicado en 2020

Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura

artículo científico publicado en 2005

ITP: a historical perspective

artículo científico publicado en 2011

Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia.

artículo científico publicado en 2005

Immune thrombocytopenia – what are the new treatment options? ⬇️

artículo científico publicado el 17 de mayo de 2013

Infliximab chimeric antitumor necrosis factor-a monoclonal antibody as potential treatment for myelodysplastic syndromes.

artículo científico publicado en 2005

International consensus report on the investigation and management of primary immune thrombocytopenia

artículo científico publicado en 2010

Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia

artículo científico publicado en 2006

Long‐term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy ⬇️

artículo científico publicado el 22 de febrero de 2013

Management of cancer-related anemia with erythropoietic agents: doubts, certainties, and concerns.

artículo científico publicado en 2005

Progress in the treatment of acute myeloid leukaemia in adults

artículo científico publicado en 2002

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study

artículo científico publicado en 2015

Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia

artículo científico publicado en 2003

Romiplostim: a breakthrough treatment for the management of immune thrombocytopenic purpura

artículo científico publicado en 2009

Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate ⬇️

artículo científico publicado el 15 de septiembre de 2010

Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults

artículo científico publicado en 2011

The Health Technology Assessment of companion diagnostics: experience of NICE.

artículo científico publicado en 2014

The alpha-5 helix of Bax is sensitive to ubiquitin-dependent degradation

artículo científico publicado en 2008

The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia ⬇️

artículo científico publicado el 1 de octubre de 2012

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

artículo científico publicado en 2010

Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis

artículo científico publicado en 2016

Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura

artículo científico publicado en 2007

Thrombopoietin receptor agonists in the treatment of thrombocytopenia

artículo científico publicado en 2009

Thrombopoietin: too much or too little ⬇️

artículo científico publicado el 1 de abril de 2012

Treatment of adults with autoimmune thrombocytopenic purpura

artículo científico publicado en 2002

United Kingdom immune thrombocytopenia registry: retrospective evaluation of bone marrow fibrosis in adult patients with primary immune thrombocytopenia and correlation with clinical findings

artículo científico publicado en 2015

What’s New in the Management of Chronic Primary Immune Thrombocytopenia in Adults and the Use of Thrombopoietin Receptor Agonists ⬇️

artículo científico publicado el 11 de mayo de 2011

Lista de obras de Adrian Newland

A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia

Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults

Adult idiopathic thrombocytopenic purpura

Alpha-galactosylceramide-driven expansion of human natural killer T cells is inhibited by prednisolone treatment

An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura

Autologous 111 In-labelled platelet sequestration studies in patients with primary immune thrombocytopenia (ITP) prior to splenectomy: a report from the United Kingdom ITP Registry

Cell death in leukemia: passenger protein regulation by topoisomerase inhibitors

Current Management of Primary Immune Thrombocytopenia

Development of romiplostim for the treatment of patients with chronic immune thrombocytopenia: from bench to bedside

Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib

Differential and tumor-specific expression of CD160 in B-cell malignancies ⬇️

Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

Emerging strategies to treat chronic immune thrombocytopenic purpura

Fatigue in immune thrombocytopenia

Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults

Fostamatinib: a review of its clinical efficacy and safety in the management of chronic adult immune thrombocytopenia

Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura

ITP: a historical perspective

Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia.

Immune thrombocytopenia – what are the new treatment options? ⬇️

Infliximab chimeric antitumor necrosis factor-a monoclonal antibody as potential treatment for myelodysplastic syndromes.

International consensus report on the investigation and management of primary immune thrombocytopenia

Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia

Long‐term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy ⬇️

Management of cancer-related anemia with erythropoietic agents: doubts, certainties, and concerns.

Progress in the treatment of acute myeloid leukaemia in adults

Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study

Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia

Romiplostim: a breakthrough treatment for the management of immune thrombocytopenic purpura

Should medical treatment options be exhausted before splenectomy is performed in adult ITP patients? A debate ⬇️

Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults

The Health Technology Assessment of companion diagnostics: experience of NICE.

The alpha-5 helix of Bax is sensitive to ubiquitin-dependent degradation

The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia ⬇️

Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis

Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura

Thrombopoietin receptor agonists in the treatment of thrombocytopenia

Thrombopoietin: too much or too little ⬇️

Treatment of adults with autoimmune thrombocytopenic purpura

United Kingdom immune thrombocytopenia registry: retrospective evaluation of bone marrow fibrosis in adult patients with primary immune thrombocytopenia and correlation with clinical findings

What’s New in the Management of Chronic Primary Immune Thrombocytopenia in Adults and the Use of Thrombopoietin Receptor Agonists ⬇️